Molecular basis of ethnic differences in drug disposition and response
- PMID: 11264478
- DOI: 10.1146/annurev.pharmtox.41.1.815
Molecular basis of ethnic differences in drug disposition and response
Abstract
Ethnicity is an important demographic variable contributing to interindividual variability in drug metabolism and response. In this rapidly expanding research area many genetic factors that account for the effects of ethnicity on pharmacokinetics, pharmacodynamics, and drug safety have been identified. This review focuses on recent developments that have improved understanding of the molecular mechanisms responsible for such interethnic differences. Genetic variations that may provide a molecular basis for ethnic differences in drug metabolizing enzymes (CYP 2C9, 2C19, 2D6, and 3A4), drug transporter (P-glycoprotein), drug receptors (adrenoceptors), and other functionally important proteins (eNOS and G proteins) are discussed. A better understanding of the molecular basis underlying ethnic differences in drug metabolism, transport, and response will contribute to improved individualization of drug therapy.
Similar articles
-
Polymorphism of human cytochrome P450 enzymes and its clinical impact.Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Drug Metab Rev. 2009. PMID: 19514967 Review.
-
Genetic factors in drug metabolism.Am Fam Physician. 2008 Jun 1;77(11):1553-60. Am Fam Physician. 2008. PMID: 18581835 Review.
-
Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs.J Clin Pharmacol. 2007 May;47(5):566-78. doi: 10.1177/0091270007299930. J Clin Pharmacol. 2007. PMID: 17442683 Review.
-
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. Pharmacol Ther. 2013. PMID: 23333322 Review.
-
Pharmacogenomics: the inherited basis for interindividual differences in drug response.Annu Rev Genomics Hum Genet. 2001;2:9-39. doi: 10.1146/annurev.genom.2.1.9. Annu Rev Genomics Hum Genet. 2001. PMID: 11701642 Review.
Cited by
-
Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.Genet Test Mol Biomarkers. 2012 Sep;16(9):1098-104. doi: 10.1089/gtmb.2012.0055. Epub 2012 Aug 22. Genet Test Mol Biomarkers. 2012. PMID: 22913530 Free PMC article.
-
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.Dis Markers. 2015;2015:542543. doi: 10.1155/2015/542543. Epub 2015 Feb 22. Dis Markers. 2015. PMID: 25802476 Free PMC article.
-
Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.Meta Gene. 2016 Jul 5;9:197-209. doi: 10.1016/j.mgene.2016.07.002. eCollection 2016 Sep. Meta Gene. 2016. PMID: 27617219 Free PMC article. Review.
-
Pharmacogenomic landscape of Indian population using whole genomes.Clin Transl Sci. 2022 Apr;15(4):866-877. doi: 10.1111/cts.13153. Epub 2022 Mar 26. Clin Transl Sci. 2022. PMID: 35338580 Free PMC article.
-
Beta blocker therapy in African American patients with heart failure.Heart Fail Rev. 2004 Apr;9(2):161-7. doi: 10.1023/B:HREV.0000046371.67163.a4. Heart Fail Rev. 2004. PMID: 15516864 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical